Pattern of mucosal tumor necrosis factor-α expression in segmental colitis associated with diverticula suggests a truly autonomous clinical entity

Inflammatory Bowel Diseases

Volumn 14, Issue 9, 2008, Pages 1315-1317

  Tursi, Antonio ^a   Inchingolo, Cosimo Damiano ^a   Nenna, Rosanna ^a   Stoppino, Giuseppe ^b   Zotti, Mariangela ^b   Panella, Carmine ^b   Ierardi, Enzo ^b  

^a Lorenzo Bonomo Hospital   (Italy)

^b Ospedali Riuniti di Foggia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADULT; AGED; BLOODY DIARRHEA; CLINICAL ARTICLE; CLINICAL FEATURE; COLITIS; COLON DIVERTICULOSIS; ENDOSCOPIC BIOPSY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY INFILTRATE; LAMINA PROPRIA; LETTER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS; SIGMOID;

AGED; COLITIS; DIVERTICULUM, COLON; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUCOUS MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 54349099966     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20438     Document Type: Letter

References (11)

1. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1974; 4:53-69.
2. Tursi A. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother. 2007; 8:299-307.
3. Harpaz N, Sachar DB. Segmental colitis associated with diverticular disease and other IBD look-alikes. J Clin Gastroenterol. 2006;40: S132-135.
4. Lamps LW, Knapple WL. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol. 2007;5:27-31.
5. Murch SH, Braegger CP, Walker-Smith JA, et al. Location of tumoral necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut. 1993;34: 1705-1709.
6. Hassan C, Zullo A, Ierardi E, et al. Tumoral necrosis factor α downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut. 2006;554:589-590.
7. Guslandi M. Segmental colitis: so what? Eur J Gastroenterol Hepatol. 2003;15:1-2.
8. Ierardi E, Monno RA, Gentile A, et al. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. J Clin Pathol. 2001;54:774-777.
9. Hassan C, Ierardi E, Burattini O, et al. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. Dig Liver Dis. 2007;39:811-817.
10. Baert FJ, D'Haens GR, Peeters M, et al. Tumour necrosis alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology. 1999;116:22-28.
11. Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol. 2008 (in press).